Literature DB >> 28509157

Extrapulmonary tuberculosis presented as fever of unknown origin in two patients with endstage kidney disease not on dialysis: usefulness of 18-FDG-PET/CT in the diagnostic localization of fever of unknown origin.

Shunsuke Yamada1,2, Kenji Ueki1, Yasuhiro Kawai1, Teppei Sako1, Yukiko Shimomura1, Akihiro Tsuchimoto1, Shigeru Tanaka1, Rei Matsui2, Hiroto Maeda2, Masanori Tokumoto2, Hiroaki Ooboshi2, Takanari Kitazono1, Kazuhiko Tsuruya3,4.   

Abstract

Tuberculosis is one of the common causes of fever of unknown origin in patients with chronic kidney disease (CKD). Extrapulmonary tuberculosis is more common in CKD patients, and is, unfortunately, often underdiagnosed despite extensive assessments. Recently, fluorine-18-deoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) has been available in the diagnosis of malignancy, inflammatory and infectious diseases, and has become a useful diagnostic tool. Here, we present two cases of endstage kidney disease who presented with fever of unknown origin at the time of dialysis initiation. In both cases, although interferon-gamma-releasing assay was positive, combined conventional diagnostic modalities such as computed tomography and gallium-citrate scintigraphy failed to detect the sites infected with tuberculosis. By contrast, extrapulmonary lesions were detected by FDG-PET/CT and successfully treated with combined anti-tuberculous drugs. Diagnosis of extrapulmonary tuberculosis was confirmed by biopsy of the affected lymph node and lumbar spine, followed by PCR of the biopsied specimen. These cases highlight the importance of considering tuberculosis as one of the differential diagnoses in pre-dialysis CKD patients with persistent fever, and the usefulness of FDG-PET/CT in the detection of infectious sites of extrapulmonary tuberculosis.

Entities:  

Keywords:  Chronic kidney disease; Dialysis initiation; Extrapulmonary tuberculosis; Fever of unknown origin; Interferon-gamma-releasing assay; Positron emission tomography

Year:  2015        PMID: 28509157      PMCID: PMC5411655          DOI: 10.1007/s13730-015-0181-2

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  25 in total

1.  Tuberculous lymphadenitis in a dialysis patient diagnosed by 18-fluorodeoxyglucose positron emission tomography and IFN-γ release assay.

Authors:  Tsuyoshi Inoue; Masaomi Nangaku; Fumihiko Hinoshita
Journal:  Am J Kidney Dis       Date:  2013-10-17       Impact factor: 8.860

2.  Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases.

Authors:  T Kälicke; A Schmitz; J H Risse; S Arens; E Keller; M Hansis; O Schmitt; H J Biersack; F Grünwald
Journal:  Eur J Nucl Med       Date:  2000-05

Review 3.  Effect of uremia on structure and function of immune system.

Authors:  Nosratola D Vaziri; Madeleine V Pahl; Albert Crum; Keith Norris
Journal:  J Ren Nutr       Date:  2012-01       Impact factor: 3.655

4.  The outcome of tuberculosis in patients on chronic hemodialysis.

Authors:  H Taskapan; C Utas; F S Oymak; I Gülmez; M Ozesmi
Journal:  Clin Nephrol       Date:  2000-08       Impact factor: 0.975

5.  Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study.

Authors:  R J Wilkinson; M Llewelyn; Z Toossi; P Patel; G Pasvol; A Lalvani; D Wright; M Latif; R N Davidson
Journal:  Lancet       Date:  2000-02-19       Impact factor: 79.321

Review 6.  Rifampicin-associated acute renal failure: pathophysiologic, immunologic, and clinical features.

Authors:  A S De Vriese; D L Robbrecht; R C Vanholder; D P Vogelaers; N H Lameire
Journal:  Am J Kidney Dis       Date:  1998-01       Impact factor: 8.860

7.  Abnormal FDG uptake on 18F-fluorodeoxyglucose positron emission tomography in patients with cancer diagnosis: case reports of tuberculous lymphadenitis.

Authors:  Selmin Ataergin; Nuri Arslan; Ahmet Ozet; M Ali Ozguven
Journal:  Intern Med       Date:  2009-01-15       Impact factor: 1.271

8.  Priorities for the treatment of latent tuberculosis infection in the United States.

Authors:  C Robert Horsburgh
Journal:  N Engl J Med       Date:  2004-05-13       Impact factor: 91.245

Review 9.  T cells and B cells in chronic renal failure.

Authors:  B Descamps-Latscha; L Chatenoud
Journal:  Semin Nephrol       Date:  1996-05       Impact factor: 5.299

Review 10.  A case of skeletal tuberculosis and psoas abscess: disease activity evaluated using (18) F-fluorodeoxyglucose positron emission tomography-computed tomography.

Authors:  Yoshifumi Kimizuka; Makoto Ishii; Koji Murakami; Kota Ishioka; Kazuma Yagi; Ken Ishii; Kota Watanabe; Kenzo Soejima; Tomoko Betsuyaku; Naoki Hasegawa
Journal:  BMC Med Imaging       Date:  2013-11-14       Impact factor: 1.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.